Stay updated on PHA-022121 Dose Study for Acute Angioedema Clinical Trial

Sign up to get notified when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Update to v3.0.2; removed the 'Back to Top' link, with no other substantive changes.
    Difference
    0.6%
    Check dated 2025-09-13T16:59:08.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.6%
    Check dated 2025-09-06T14:28:49.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, which are crucial for users seeking specific information about the study. Additionally, several study status updates have been included, indicating ongoing research activities.
    Difference
    46%
    Check dated 2025-08-30T11:18:08.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:32:05.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-08T23:49:43.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T19:19:51.000Z thumbnail image

Stay in the know with updates to PHA-022121 Dose Study for Acute Angioedema Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.